Loading…
Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children
Saved in:
| Published in: | Leukemia 2020-12, Vol.34 (12), p.3382-3387 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3 |
| container_end_page | 3387 |
| container_issue | 12 |
| container_start_page | 3382 |
| container_title | Leukemia |
| container_volume | 34 |
| creator | Pan, Jing Tan, Yue Deng, Biping Tong, Chunrong Hua, Lin Ling, Zhuojun Song, Weiliang Xu, Jinlong Duan, Jiajia Wang, Zelin Guo, Huilin Yu, Xinjian Chang, Alex H. Zheng, Qinlong Feng, Xiaoming |
| description | |
| doi_str_mv | 10.1038/s41375-020-0831-z |
| format | article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2396310135</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A650886443</galeid><sourcerecordid>A650886443</sourcerecordid><originalsourceid>FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3</originalsourceid><addsrcrecordid>eNp1kl-L1DAUxYMo7rj6AXyRgCC-ZDdp_rR9nB1dFQYUGZ9Dmt7MdOkkY5IKu-B3N3VW1xUlD4Xc37npORyEnjN6xihvzpNgvJaEVpTQhjNy8wAtmKgVkVKyh2hBm6Ymqq3ECXqS0hWl81A9Rie84kJR1SzQ98sIXyfwGQdrpxjBW8DB4dUb1hIPW5OHb4AjjOaQABuXIf6c4dXyM95g43tsg09hHPqCBo_zDqI5XOPBYybw5pPkZD9lk6HH8TziC7Jcr7HdDWNf3nqKHjkzJnh2-z1FXy7fblbvyfrjuw-r5ZpYUdNMOtoo1jnmesZqyVtqqJVAWQuthK6vha1s11BnuRVQfDEA1XZW0Rp6qhzwU_T6uPcQQ3Gbst4PycI4Gg9hSrrireKMMi4L-vIv9CpM0Ze_05WoeSWpUPyO2poR9OBdyNHYealeKllyV0LM1Nk_qHJ62A8lNnBDub8nePWHYAdmzLuS7TQnm-6D7AjaGFKK4PQhDnsTrzWjeu6GPnZDl27ouRv6pmhe3Dqbuj30vxW_ylCA6gikMvJbiHfW_7_1B1O8v9Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473250463</pqid></control><display><type>article</type><title>Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children</title><source>Nexis UK</source><source>Springer Nature</source><creator>Pan, Jing ; Tan, Yue ; Deng, Biping ; Tong, Chunrong ; Hua, Lin ; Ling, Zhuojun ; Song, Weiliang ; Xu, Jinlong ; Duan, Jiajia ; Wang, Zelin ; Guo, Huilin ; Yu, Xinjian ; Chang, Alex H. ; Zheng, Qinlong ; Feng, Xiaoming</creator><creatorcontrib>Pan, Jing ; Tan, Yue ; Deng, Biping ; Tong, Chunrong ; Hua, Lin ; Ling, Zhuojun ; Song, Weiliang ; Xu, Jinlong ; Duan, Jiajia ; Wang, Zelin ; Guo, Huilin ; Yu, Xinjian ; Chang, Alex H. ; Zheng, Qinlong ; Feng, Xiaoming</creatorcontrib><identifier>ISSN: 0887-6924</identifier><identifier>EISSN: 1476-5551</identifier><identifier>DOI: 10.1038/s41375-020-0831-z</identifier><identifier>PMID: 32346068</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>13/31 ; 38/91 ; 45/22 ; 45/23 ; 45/43 ; 45/77 ; 45/90 ; 45/91 ; 692/308/575 ; 692/699/67/1059/2325 ; Acute lymphocytic leukemia ; Antigens, CD19 - genetics ; Cancer Research ; Care and treatment ; CD19 antigen ; Cellular proteins ; Cellular therapy ; Child ; Consolidation Chemotherapy - methods ; Critical Care Medicine ; Development and progression ; Genetic aspects ; Health aspects ; Hematology ; Humans ; Intensive ; Internal Medicine ; Letter ; Leukemia, Biphenotypic, Acute - drug therapy ; Leukemia, Biphenotypic, Acute - genetics ; Medicine ; Medicine & Public Health ; Methods ; Mutation - genetics ; Oncology ; p53 Protein ; Patient outcomes ; Receptors, Antigen, T-Cell - genetics ; Receptors, Chimeric Antigen - genetics ; Recurrence ; Tumor Suppressor Protein p53 - genetics</subject><ispartof>Leukemia, 2020-12, Vol.34 (12), p.3382-3387</ispartof><rights>The Author(s), under exclusive licence to Springer Nature Limited 2020</rights><rights>COPYRIGHT 2020 Nature Publishing Group</rights><rights>The Author(s), under exclusive licence to Springer Nature Limited 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3</citedby><cites>FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3</cites><orcidid>0000-0002-8785-0336</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32346068$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pan, Jing</creatorcontrib><creatorcontrib>Tan, Yue</creatorcontrib><creatorcontrib>Deng, Biping</creatorcontrib><creatorcontrib>Tong, Chunrong</creatorcontrib><creatorcontrib>Hua, Lin</creatorcontrib><creatorcontrib>Ling, Zhuojun</creatorcontrib><creatorcontrib>Song, Weiliang</creatorcontrib><creatorcontrib>Xu, Jinlong</creatorcontrib><creatorcontrib>Duan, Jiajia</creatorcontrib><creatorcontrib>Wang, Zelin</creatorcontrib><creatorcontrib>Guo, Huilin</creatorcontrib><creatorcontrib>Yu, Xinjian</creatorcontrib><creatorcontrib>Chang, Alex H.</creatorcontrib><creatorcontrib>Zheng, Qinlong</creatorcontrib><creatorcontrib>Feng, Xiaoming</creatorcontrib><title>Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children</title><title>Leukemia</title><addtitle>Leukemia</addtitle><addtitle>Leukemia</addtitle><subject>13/31</subject><subject>38/91</subject><subject>45/22</subject><subject>45/23</subject><subject>45/43</subject><subject>45/77</subject><subject>45/90</subject><subject>45/91</subject><subject>692/308/575</subject><subject>692/699/67/1059/2325</subject><subject>Acute lymphocytic leukemia</subject><subject>Antigens, CD19 - genetics</subject><subject>Cancer Research</subject><subject>Care and treatment</subject><subject>CD19 antigen</subject><subject>Cellular proteins</subject><subject>Cellular therapy</subject><subject>Child</subject><subject>Consolidation Chemotherapy - methods</subject><subject>Critical Care Medicine</subject><subject>Development and progression</subject><subject>Genetic aspects</subject><subject>Health aspects</subject><subject>Hematology</subject><subject>Humans</subject><subject>Intensive</subject><subject>Internal Medicine</subject><subject>Letter</subject><subject>Leukemia, Biphenotypic, Acute - drug therapy</subject><subject>Leukemia, Biphenotypic, Acute - genetics</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Methods</subject><subject>Mutation - genetics</subject><subject>Oncology</subject><subject>p53 Protein</subject><subject>Patient outcomes</subject><subject>Receptors, Antigen, T-Cell - genetics</subject><subject>Receptors, Chimeric Antigen - genetics</subject><subject>Recurrence</subject><subject>Tumor Suppressor Protein p53 - genetics</subject><issn>0887-6924</issn><issn>1476-5551</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp1kl-L1DAUxYMo7rj6AXyRgCC-ZDdp_rR9nB1dFQYUGZ9Dmt7MdOkkY5IKu-B3N3VW1xUlD4Xc37npORyEnjN6xihvzpNgvJaEVpTQhjNy8wAtmKgVkVKyh2hBm6Ymqq3ECXqS0hWl81A9Rie84kJR1SzQ98sIXyfwGQdrpxjBW8DB4dUb1hIPW5OHb4AjjOaQABuXIf6c4dXyM95g43tsg09hHPqCBo_zDqI5XOPBYybw5pPkZD9lk6HH8TziC7Jcr7HdDWNf3nqKHjkzJnh2-z1FXy7fblbvyfrjuw-r5ZpYUdNMOtoo1jnmesZqyVtqqJVAWQuthK6vha1s11BnuRVQfDEA1XZW0Rp6qhzwU_T6uPcQQ3Gbst4PycI4Gg9hSrrireKMMi4L-vIv9CpM0Ze_05WoeSWpUPyO2poR9OBdyNHYealeKllyV0LM1Nk_qHJ62A8lNnBDub8nePWHYAdmzLuS7TQnm-6D7AjaGFKK4PQhDnsTrzWjeu6GPnZDl27ouRv6pmhe3Dqbuj30vxW_ylCA6gikMvJbiHfW_7_1B1O8v9Y</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Pan, Jing</creator><creator>Tan, Yue</creator><creator>Deng, Biping</creator><creator>Tong, Chunrong</creator><creator>Hua, Lin</creator><creator>Ling, Zhuojun</creator><creator>Song, Weiliang</creator><creator>Xu, Jinlong</creator><creator>Duan, Jiajia</creator><creator>Wang, Zelin</creator><creator>Guo, Huilin</creator><creator>Yu, Xinjian</creator><creator>Chang, Alex H.</creator><creator>Zheng, Qinlong</creator><creator>Feng, Xiaoming</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7T5</scope><scope>7T7</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-8785-0336</orcidid></search><sort><creationdate>20201201</creationdate><title>Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children</title><author>Pan, Jing ; Tan, Yue ; Deng, Biping ; Tong, Chunrong ; Hua, Lin ; Ling, Zhuojun ; Song, Weiliang ; Xu, Jinlong ; Duan, Jiajia ; Wang, Zelin ; Guo, Huilin ; Yu, Xinjian ; Chang, Alex H. ; Zheng, Qinlong ; Feng, Xiaoming</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>13/31</topic><topic>38/91</topic><topic>45/22</topic><topic>45/23</topic><topic>45/43</topic><topic>45/77</topic><topic>45/90</topic><topic>45/91</topic><topic>692/308/575</topic><topic>692/699/67/1059/2325</topic><topic>Acute lymphocytic leukemia</topic><topic>Antigens, CD19 - genetics</topic><topic>Cancer Research</topic><topic>Care and treatment</topic><topic>CD19 antigen</topic><topic>Cellular proteins</topic><topic>Cellular therapy</topic><topic>Child</topic><topic>Consolidation Chemotherapy - methods</topic><topic>Critical Care Medicine</topic><topic>Development and progression</topic><topic>Genetic aspects</topic><topic>Health aspects</topic><topic>Hematology</topic><topic>Humans</topic><topic>Intensive</topic><topic>Internal Medicine</topic><topic>Letter</topic><topic>Leukemia, Biphenotypic, Acute - drug therapy</topic><topic>Leukemia, Biphenotypic, Acute - genetics</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Methods</topic><topic>Mutation - genetics</topic><topic>Oncology</topic><topic>p53 Protein</topic><topic>Patient outcomes</topic><topic>Receptors, Antigen, T-Cell - genetics</topic><topic>Receptors, Chimeric Antigen - genetics</topic><topic>Recurrence</topic><topic>Tumor Suppressor Protein p53 - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pan, Jing</creatorcontrib><creatorcontrib>Tan, Yue</creatorcontrib><creatorcontrib>Deng, Biping</creatorcontrib><creatorcontrib>Tong, Chunrong</creatorcontrib><creatorcontrib>Hua, Lin</creatorcontrib><creatorcontrib>Ling, Zhuojun</creatorcontrib><creatorcontrib>Song, Weiliang</creatorcontrib><creatorcontrib>Xu, Jinlong</creatorcontrib><creatorcontrib>Duan, Jiajia</creatorcontrib><creatorcontrib>Wang, Zelin</creatorcontrib><creatorcontrib>Guo, Huilin</creatorcontrib><creatorcontrib>Yu, Xinjian</creatorcontrib><creatorcontrib>Chang, Alex H.</creatorcontrib><creatorcontrib>Zheng, Qinlong</creatorcontrib><creatorcontrib>Feng, Xiaoming</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Leukemia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pan, Jing</au><au>Tan, Yue</au><au>Deng, Biping</au><au>Tong, Chunrong</au><au>Hua, Lin</au><au>Ling, Zhuojun</au><au>Song, Weiliang</au><au>Xu, Jinlong</au><au>Duan, Jiajia</au><au>Wang, Zelin</au><au>Guo, Huilin</au><au>Yu, Xinjian</au><au>Chang, Alex H.</au><au>Zheng, Qinlong</au><au>Feng, Xiaoming</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children</atitle><jtitle>Leukemia</jtitle><stitle>Leukemia</stitle><addtitle>Leukemia</addtitle><date>2020-12-01</date><risdate>2020</risdate><volume>34</volume><issue>12</issue><spage>3382</spage><epage>3387</epage><pages>3382-3387</pages><issn>0887-6924</issn><eissn>1476-5551</eissn><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>32346068</pmid><doi>10.1038/s41375-020-0831-z</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8785-0336</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0887-6924 |
| ispartof | Leukemia, 2020-12, Vol.34 (12), p.3382-3387 |
| issn | 0887-6924 1476-5551 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2396310135 |
| source | Nexis UK; Springer Nature |
| subjects | 13/31 38/91 45/22 45/23 45/43 45/77 45/90 45/91 692/308/575 692/699/67/1059/2325 Acute lymphocytic leukemia Antigens, CD19 - genetics Cancer Research Care and treatment CD19 antigen Cellular proteins Cellular therapy Child Consolidation Chemotherapy - methods Critical Care Medicine Development and progression Genetic aspects Health aspects Hematology Humans Intensive Internal Medicine Letter Leukemia, Biphenotypic, Acute - drug therapy Leukemia, Biphenotypic, Acute - genetics Medicine Medicine & Public Health Methods Mutation - genetics Oncology p53 Protein Patient outcomes Receptors, Antigen, T-Cell - genetics Receptors, Chimeric Antigen - genetics Recurrence Tumor Suppressor Protein p53 - genetics |
| title | Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T18%3A20%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frequent%20occurrence%20of%20CD19-negative%20relapse%20after%20CD19%20CAR%20T%20and%20consolidation%20therapy%20in%2014%20TP53-mutated%20r/r%20B-ALL%20children&rft.jtitle=Leukemia&rft.au=Pan,%20Jing&rft.date=2020-12-01&rft.volume=34&rft.issue=12&rft.spage=3382&rft.epage=3387&rft.pages=3382-3387&rft.issn=0887-6924&rft.eissn=1476-5551&rft_id=info:doi/10.1038/s41375-020-0831-z&rft_dat=%3Cgale_proqu%3EA650886443%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c470t-b0861bf1fd1175390a0c5e019e95ebd74c2cb80fc3c4e6061ee69bc607ed06fe3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2473250463&rft_id=info:pmid/32346068&rft_galeid=A650886443&rfr_iscdi=true |